当前位置:首页 - 行情中心 - 伟思医疗(688580) - 财务分析 - 现金流量表

伟思医疗

(688580)

  

流通市值:36.97亿  总市值:36.97亿
流通股本:9577.13万   总股本:9577.13万

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金363,970,519.33246,589,862.04115,221,492.03526,018,082.02
  收到的税费返还10,547,439.957,206,626.242,574,060.4317,392,902.16
  收到其他与经营活动有关的现金6,376,174.236,054,947.344,079,852.5811,905,357.34
  经营活动现金流入小计380,894,133.51259,851,435.62121,875,405.04555,316,341.52
  购买商品、接受劳务支付的现金102,609,842.4660,357,681.9636,153,584.27134,203,067.86
  支付给职工以及为职工支付的现金115,726,593.5181,249,784.3248,699,452.07138,100,523.52
  支付的各项税费46,923,868.8137,065,317.5712,540,395.7653,076,975.42
  支付其他与经营活动有关的现金35,276,256.5221,919,076.38,588,188.3653,191,465.06
  经营活动现金流出小计300,536,561.3200,591,860.15105,981,620.46378,572,031.86
  经营活动产生的现金流量净额80,357,572.2159,259,575.4715,893,784.58176,744,309.66
二、投资活动产生的现金流量:
  收回投资收到的现金2,561,000,0001,716,000,000866,000,0003,521,040,327.16
  取得投资收益收到的现金8,939,225.635,834,397.972,550,983.4212,533,301.1
  处置固定资产、无形资产和其他长期资产收回的现金净额66,532,433.7466,626,502.9271,342,00041,650,389.38
  收到的其他与投资活动有关的现金---1,200,000
  投资活动现金流入小计2,636,471,659.371,788,460,900.89939,892,983.423,576,424,017.64
  购建固定资产、无形资产和其他长期资产支付的现金101,314,607.9190,638,317.5680,726,075.25118,117,619.25
  投资支付的现金2,661,000,0001,816,000,0001,166,000,0003,571,000,000
  取得子公司及其他营业单位支付的现金---29,648,485
  支付其他与投资活动有关的现金1,050,000900,000900,0001,150,000
  投资活动现金流出小计2,763,364,607.911,907,538,317.561,247,626,075.253,719,916,104.25
  投资活动产生的现金流量净额-126,892,948.54-119,077,416.67-307,733,091.83-143,492,086.61
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金103,560,041.01103,560,041.01-76,569,346.4
  支付其他与筹资活动有关的现金130,538.3833,939.98-877,282.9
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计103,690,579.39103,593,980.99-77,446,629.3
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-103,690,579.39-103,593,980.99--77,446,629.3
四、汇率变动对现金及现金等价物的影响-194,786.4-116,597.95-46,718.16-40,814.55
五、现金及现金等价物净增加额-150,420,742.12-163,528,420.14-291,886,025.41-44,235,220.8
  加:期初现金及现金等价物余额1,022,971,611.931,022,971,611.931,022,971,611.931,067,206,832.73
  期末现金及现金等价物余额872,550,869.81859,443,191.79731,085,586.521,022,971,611.93
补充资料:
  净利润-100,122,719.93-138,072,645.5
  资产减值准备-64,656.8-430,627.75
  固定资产和投资性房地产折旧-8,788,785.61-15,568,748.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-8,788,785.61-15,568,748.69
  无形资产摊销-5,561,881.89-10,974,095.14
  长期待摊费用摊销-534,243.64-1,322,287.81
  处置固定资产、无形资产和其他长期资产的损失--33,165,689.15-880.57
  固定资产报废损失-152,559.02--
  公允价值变动损失----4,835,413.96
  财务费用-7,626.44-1,308,051.09
  投资损失--5,834,397.97--12,533,301.1
  递延所得税-1,188,806.08--521,291.88
  其中:递延所得税资产减少-1,215,785.1--455,252.01
    递延所得税负债增加--26,979.02--66,039.87
  存货的减少-778,315.83--3,900,453.44
  经营性应收项目的减少--8,743,426.87--35,595,255.84
  经营性应付项目的增加--12,074,835.34-61,707,447.05
  其他-1,510,930.8-2,481,992.42
  不涉及现金收支的投资和筹资活动金额其他项目-0-159,008.79
  现金的期末余额-859,443,191.79-1,022,971,611.93
  减:现金的期初余额-1,022,971,611.93-1,067,206,832.73
  现金及现金等价物的净增加额--163,528,420.14--44,235,220.8
公告日期2026-10-272026-08-262026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑